Literature DB >> 1690239

Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule.

C B Brown1, C E Hart, D M Curtis, M C Bailey, K Kaushansky.   

Abstract

Using a series of mutant and chimeric human-mouse granulocyte-macrophage-CSF molecules the binding epitopes of two neutralizing mAb antibodies to human GM-CSF have been mapped. Both intact antibody and Fab fragments neutralize the biologic activity of human GM-CSF. The epitope of one of the antibodies contains residues widely separated in the primary structure of the growth factor that suggests that these two regions are adjacent in the tertiary structure of the molecule. In addition, evidence is presented that both mAb neutralize the activity of this cytokine by blocking the receptor binding domain of human GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690239

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

Authors:  R Pacifici; C Brown; E Puscheck; E Friedrich; E Slatopolsky; D Maggio; R McCracken; L V Avioli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

4.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF.

Authors:  M R Schaafsma; J H Falkenburg; N Duinkerken; J Van Snick; J E Landegent; R Willemze; W E Fibbe
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

6.  Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions.

Authors:  J M Von Feldt; C Monfardini; T Kieber-Emmons; D Voet; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding.

Authors:  A F Lopez; M F Shannon; T Hercus; N A Nicola; B Cambareri; M Dottore; M J Layton; L Eglinton; M A Vadas
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.